Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

YM-087 in phase I for CHF

April 12, 1996

BDNF, CNTF protect against metabolic stress in vitro

April 12, 1996

Lubeluzole + DCLHb potentially effective in stroke

April 12, 1996

COX-2 inhibitor reported by Searle

April 12, 1996

T cell receptor vaccine effective in MS

April 12, 1996

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Conjugated estrogens + pravastatin effective in treating hypercholesterolemia in women

April 12, 1996

New alpha2-adrenoceptor agonist reported by Allergan

April 12, 1996

NT-3 lessens cisplatin toxicity in rats

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...